カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の免疫抑制剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Immunosuppressive Agents Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19415）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19415
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の免疫抑制剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

免疫抑制剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の免疫抑制剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

免疫抑制剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・シクロスポリン、タクロリムス、エベロリムス、シロリムス、ミコフェノール酸

用途別セグメントは次のように区分されます。
・自然免疫疾患治療、臓器移植、がん治療、その他

世界の免疫抑制剤市場の主要な市場プレーヤーは以下のとおりです。
・Huadong Medicine、Fujisawa Pharmaceutical Co Ltd、Astellas、Roche、Novartis、North China Pharmaceutical Group

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、免疫抑制剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な免疫抑制剤メーカーの企業概要、2019年～2022年までの免疫抑制剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な免疫抑制剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別免疫抑制剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの免疫抑制剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での免疫抑制剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および免疫抑制剤の産業チェーンを掲載しています。
・第13、14、15章では、免疫抑制剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 免疫抑制剤の概要
- 種類別分析（2017年vs2021年vs2028年）：シクロスポリン、タクロリムス、エベロリムス、シロリムス、ミコフェノール酸
- 用途別分析（2017年vs2021年vs2028年）：自然免疫疾患治療、臓器移植、がん治療、その他
- 世界の免疫抑制剤市場規模・予測
- 世界の免疫抑制剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Huadong Medicine、Fujisawa Pharmaceutical Co Ltd、Astellas、Roche、Novartis、North China Pharmaceutical Group
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：シクロスポリン、タクロリムス、エベロリムス、シロリムス、ミコフェノール酸
・用途別分析2017年-2028年：自然免疫疾患治療、臓器移植、がん治療、その他
・免疫抑制剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・免疫抑制剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・免疫抑制剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・免疫抑制剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・免疫抑制剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Immunosuppressive Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Immunosuppressive Agents market size is estimated to be worth US$ 21540 million in 2021 and is forecast to a readjusted size of USD 45590 million by 2028 with a CAGR of 11.3% during review period. Innate Immune Disease Treatment accounting for % of the Immunosuppressive Agents global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cyclosporin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Immunosuppressive Agents include Huadong Medicine, Fujisawa Pharmaceutical Co Ltd, Astellas, Roche, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immunosuppressive Agents market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cyclosporin
Tacrolimus
Everolimus
Sirolimus
Mycophenolic Acid
Market segment by Application can be divided into
Innate Immune Disease Treatment
Organ Transplant
Cancer Treatment
Other
The key market players for global Immunosuppressive Agents market are listed below:
Huadong Medicine
Fujisawa Pharmaceutical Co Ltd
Astellas
Roche
Novartis
North China Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immunosuppressive Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immunosuppressive Agents, with price, sales, revenue and global market share of Immunosuppressive Agents from 2019 to 2022.
Chapter 3, the Immunosuppressive Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunosuppressive Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Immunosuppressive Agents market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunosuppressive Agents.
Chapter 13, 14, and 15, to describe Immunosuppressive Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Immunosuppressive Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immunosuppressive Agents Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cyclosporin
1.2.3 Tacrolimus
1.2.4 Everolimus
1.2.5 Sirolimus
1.2.6 Mycophenolic Acid
1.3 Market Analysis by Application
1.3.1 Overview: Global Immunosuppressive Agents Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Innate Immune Disease Treatment
1.3.3 Organ Transplant
1.3.4 Cancer Treatment
1.3.5 Other
1.4 Global Immunosuppressive Agents Market Size & Forecast
1.4.1 Global Immunosuppressive Agents Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Immunosuppressive Agents Sales in Volume (2017-2028)
1.4.3 Global Immunosuppressive Agents Price (2017-2028)
1.5 Global Immunosuppressive Agents Production Capacity Analysis
1.5.1 Global Immunosuppressive Agents Total Production Capacity (2017-2028)
1.5.2 Global Immunosuppressive Agents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunosuppressive Agents Market Drivers
1.6.2 Immunosuppressive Agents Market Restraints
1.6.3 Immunosuppressive Agents Trends Analysis
2 Manufacturers Profiles
2.1 Huadong Medicine
2.1.1 Huadong Medicine Details
2.1.2 Huadong Medicine Major Business
2.1.3 Huadong Medicine Immunosuppressive Agents Product and Services
2.1.4 Huadong Medicine Immunosuppressive Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Fujisawa Pharmaceutical Co Ltd
2.2.1 Fujisawa Pharmaceutical Co Ltd Details
2.2.2 Fujisawa Pharmaceutical Co Ltd Major Business
2.2.3 Fujisawa Pharmaceutical Co Ltd Immunosuppressive Agents Product and Services
2.2.4 Fujisawa Pharmaceutical Co Ltd Immunosuppressive Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Astellas
2.3.1 Astellas Details
2.3.2 Astellas Major Business
2.3.3 Astellas Immunosuppressive Agents Product and Services
2.3.4 Astellas Immunosuppressive Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Immunosuppressive Agents Product and Services
2.4.4 Roche Immunosuppressive Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Immunosuppressive Agents Product and Services
2.5.4 Novartis Immunosuppressive Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 North China Pharmaceutical Group
2.6.1 North China Pharmaceutical Group Details
2.6.2 North China Pharmaceutical Group Major Business
2.6.3 North China Pharmaceutical Group Immunosuppressive Agents Product and Services
2.6.4 North China Pharmaceutical Group Immunosuppressive Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Immunosuppressive Agents Breakdown Data by Manufacturer
3.1 Global Immunosuppressive Agents Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Immunosuppressive Agents Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Immunosuppressive Agents
3.4 Market Concentration Rate
3.4.1 Top 3 Immunosuppressive Agents Manufacturer Market Share in 2021
3.4.2 Top 6 Immunosuppressive Agents Manufacturer Market Share in 2021
3.5 Global Immunosuppressive Agents Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Immunosuppressive Agents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Immunosuppressive Agents Market Size by Region
4.1.1 Global Immunosuppressive Agents Sales in Volume by Region (2017-2028)
4.1.2 Global Immunosuppressive Agents Revenue by Region (2017-2028)
4.2 North America Immunosuppressive Agents Revenue (2017-2028)
4.3 Europe Immunosuppressive Agents Revenue (2017-2028)
4.4 Asia-Pacific Immunosuppressive Agents Revenue (2017-2028)
4.5 South America Immunosuppressive Agents Revenue (2017-2028)
4.6 Middle East and Africa Immunosuppressive Agents Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Immunosuppressive Agents Sales in Volume by Type (2017-2028)
5.2 Global Immunosuppressive Agents Revenue by Type (2017-2028)
5.3 Global Immunosuppressive Agents Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Immunosuppressive Agents Sales in Volume by Application (2017-2028)
6.2 Global Immunosuppressive Agents Revenue by Application (2017-2028)
6.3 Global Immunosuppressive Agents Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Immunosuppressive Agents Sales by Type (2017-2028)
7.2 North America Immunosuppressive Agents Sales by Application (2017-2028)
7.3 North America Immunosuppressive Agents Market Size by Country
7.3.1 North America Immunosuppressive Agents Sales in Volume by Country (2017-2028)
7.3.2 North America Immunosuppressive Agents Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Immunosuppressive Agents Sales by Type (2017-2028)
8.2 Europe Immunosuppressive Agents Sales by Application (2017-2028)
8.3 Europe Immunosuppressive Agents Market Size by Country
8.3.1 Europe Immunosuppressive Agents Sales in Volume by Country (2017-2028)
8.3.2 Europe Immunosuppressive Agents Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Immunosuppressive Agents Sales by Type (2017-2028)
9.2 Asia-Pacific Immunosuppressive Agents Sales by Application (2017-2028)
9.3 Asia-Pacific Immunosuppressive Agents Market Size by Region
9.3.1 Asia-Pacific Immunosuppressive Agents Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Immunosuppressive Agents Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Immunosuppressive Agents Sales by Type (2017-2028)
10.2 South America Immunosuppressive Agents Sales by Application (2017-2028)
10.3 South America Immunosuppressive Agents Market Size by Country
10.3.1 South America Immunosuppressive Agents Sales in Volume by Country (2017-2028)
10.3.2 South America Immunosuppressive Agents Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immunosuppressive Agents Sales by Type (2017-2028)
11.2 Middle East & Africa Immunosuppressive Agents Sales by Application (2017-2028)
11.3 Middle East & Africa Immunosuppressive Agents Market Size by Country
11.3.1 Middle East & Africa Immunosuppressive Agents Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Immunosuppressive Agents Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Immunosuppressive Agents and Key Manufacturers
12.2 Manufacturing Costs Percentage of Immunosuppressive Agents
12.3 Immunosuppressive Agents Production Process
12.4 Immunosuppressive Agents Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Immunosuppressive Agents Typical Distributors
13.3 Immunosuppressive Agents Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Immunosuppressive Agents Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Immunosuppressive Agents Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 4. Huadong Medicine Major Business
Table 5. Huadong Medicine Immunosuppressive Agents Product and Services
Table 6. Huadong Medicine Immunosuppressive Agents Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Fujisawa Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Fujisawa Pharmaceutical Co Ltd Major Business
Table 9. Fujisawa Pharmaceutical Co Ltd Immunosuppressive Agents Product and Services
Table 10. Fujisawa Pharmaceutical Co Ltd Immunosuppressive Agents Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Astellas Basic Information, Manufacturing Base and Competitors
Table 12. Astellas Major Business
Table 13. Astellas Immunosuppressive Agents Product and Services
Table 14. Astellas Immunosuppressive Agents Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Immunosuppressive Agents Product and Services
Table 18. Roche Immunosuppressive Agents Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Immunosuppressive Agents Product and Services
Table 22. Novartis Immunosuppressive Agents Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. North China Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 24. North China Pharmaceutical Group Major Business
Table 25. North China Pharmaceutical Group Immunosuppressive Agents Product and Services
Table 26. North China Pharmaceutical Group Immunosuppressive Agents Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Immunosuppressive Agents Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 28. Global Immunosuppressive Agents Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Immunosuppressive Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Immunosuppressive Agents Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 31. Head Office and Immunosuppressive Agents Production Site of Key Manufacturer
Table 32. Immunosuppressive Agents New Entrant and Capacity Expansion Plans
Table 33. Immunosuppressive Agents Mergers & Acquisitions in the Past Five Years
Table 34. Global Immunosuppressive Agents Sales by Region (2017-2022) & (Kiloton)
Table 35. Global Immunosuppressive Agents Sales by Region (2023-2028) & (Kiloton)
Table 36. Global Immunosuppressive Agents Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Immunosuppressive Agents Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Immunosuppressive Agents Sales by Type (2017-2022) & (Kiloton)
Table 39. Global Immunosuppressive Agents Sales by Type (2023-2028) & (Kiloton)
Table 40. Global Immunosuppressive Agents Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Immunosuppressive Agents Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Immunosuppressive Agents Price by Type (2017-2022) & (US$/Ton)
Table 43. Global Immunosuppressive Agents Price by Type (2023-2028) & (US$/Ton)
Table 44. Global Immunosuppressive Agents Sales by Application (2017-2022) & (Kiloton)
Table 45. Global Immunosuppressive Agents Sales by Application (2023-2028) & (Kiloton)
Table 46. Global Immunosuppressive Agents Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Immunosuppressive Agents Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Immunosuppressive Agents Price by Application (2017-2022) & (US$/Ton)
Table 49. Global Immunosuppressive Agents Price by Application (2023-2028) & (US$/Ton)
Table 50. North America Immunosuppressive Agents Sales by Country (2017-2022) & (Kiloton)
Table 51. North America Immunosuppressive Agents Sales by Country (2023-2028) & (Kiloton)
Table 52. North America Immunosuppressive Agents Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Immunosuppressive Agents Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Immunosuppressive Agents Sales by Type (2017-2022) & (Kiloton)
Table 55. North America Immunosuppressive Agents Sales by Type (2023-2028) & (Kiloton)
Table 56. North America Immunosuppressive Agents Sales by Application (2017-2022) & (Kiloton)
Table 57. North America Immunosuppressive Agents Sales by Application (2023-2028) & (Kiloton)
Table 58. Europe Immunosuppressive Agents Sales by Country (2017-2022) & (Kiloton)
Table 59. Europe Immunosuppressive Agents Sales by Country (2023-2028) & (Kiloton)
Table 60. Europe Immunosuppressive Agents Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Immunosuppressive Agents Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Immunosuppressive Agents Sales by Type (2017-2022) & (Kiloton)
Table 63. Europe Immunosuppressive Agents Sales by Type (2023-2028) & (Kiloton)
Table 64. Europe Immunosuppressive Agents Sales by Application (2017-2022) & (Kiloton)
Table 65. Europe Immunosuppressive Agents Sales by Application (2023-2028) & (Kiloton)
Table 66. Asia-Pacific Immunosuppressive Agents Sales by Region (2017-2022) & (Kiloton)
Table 67. Asia-Pacific Immunosuppressive Agents Sales by Region (2023-2028) & (Kiloton)
Table 68. Asia-Pacific Immunosuppressive Agents Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Immunosuppressive Agents Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Immunosuppressive Agents Sales by Type (2017-2022) & (Kiloton)
Table 71. Asia-Pacific Immunosuppressive Agents Sales by Type (2023-2028) & (Kiloton)
Table 72. Asia-Pacific Immunosuppressive Agents Sales by Application (2017-2022) & (Kiloton)
Table 73. Asia-Pacific Immunosuppressive Agents Sales by Application (2023-2028) & (Kiloton)
Table 74. South America Immunosuppressive Agents Sales by Country (2017-2022) & (Kiloton)
Table 75. South America Immunosuppressive Agents Sales by Country (2023-2028) & (Kiloton)
Table 76. South America Immunosuppressive Agents Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Immunosuppressive Agents Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Immunosuppressive Agents Sales by Type (2017-2022) & (Kiloton)
Table 79. South America Immunosuppressive Agents Sales by Type (2023-2028) & (Kiloton)
Table 80. South America Immunosuppressive Agents Sales by Application (2017-2022) & (Kiloton)
Table 81. South America Immunosuppressive Agents Sales by Application (2023-2028) & (Kiloton)
Table 82. Middle East & Africa Immunosuppressive Agents Sales by Region (2017-2022) & (Kiloton)
Table 83. Middle East & Africa Immunosuppressive Agents Sales by Region (2023-2028) & (Kiloton)
Table 84. Middle East & Africa Immunosuppressive Agents Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Immunosuppressive Agents Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Immunosuppressive Agents Sales by Type (2017-2022) & (Kiloton)
Table 87. Middle East & Africa Immunosuppressive Agents Sales by Type (2023-2028) & (Kiloton)
Table 88. Middle East & Africa Immunosuppressive Agents Sales by Application (2017-2022) & (Kiloton)
Table 89. Middle East & Africa Immunosuppressive Agents Sales by Application (2023-2028) & (Kiloton)
Table 90. Immunosuppressive Agents Raw Material
Table 91. Key Manufacturers of Immunosuppressive Agents Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Immunosuppressive Agents Typical Distributors
Table 95. Immunosuppressive Agents Typical Customers
List of Figures
Figure 1. Immunosuppressive Agents Picture
Figure 2. Global Immunosuppressive Agents Revenue Market Share by Type in 2021
Figure 3. Cyclosporin
Figure 4. Tacrolimus
Figure 5. Everolimus
Figure 6. Sirolimus
Figure 7. Mycophenolic Acid
Figure 8. Global Immunosuppressive Agents Revenue Market Share by Application in 2021
Figure 9. Innate Immune Disease Treatment
Figure 10. Organ Transplant
Figure 11. Cancer Treatment
Figure 12. Other
Figure 13. Global Immunosuppressive Agents Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 14. Global Immunosuppressive Agents Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Immunosuppressive Agents Sales (2017-2028) & (Kiloton)
Figure 16. Global Immunosuppressive Agents Price (2017-2028) & (US$/Ton)
Figure 17. Global Immunosuppressive Agents Production Capacity (2017-2028) & (Kiloton)
Figure 18. Global Immunosuppressive Agents Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Immunosuppressive Agents Market Drivers
Figure 20. Immunosuppressive Agents Market Restraints
Figure 21. Immunosuppressive Agents Market Trends
Figure 22. Global Immunosuppressive Agents Sales Market Share by Manufacturer in 2021
Figure 23. Global Immunosuppressive Agents Revenue Market Share by Manufacturer in 2021
Figure 24. Immunosuppressive Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Immunosuppressive Agents Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Immunosuppressive Agents Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Immunosuppressive Agents Sales Market Share by Region (2017-2028)
Figure 28. Global Immunosuppressive Agents Revenue Market Share by Region (2017-2028)
Figure 29. North America Immunosuppressive Agents Revenue (2017-2028) & (USD Million)
Figure 30. Europe Immunosuppressive Agents Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Immunosuppressive Agents Revenue (2017-2028) & (USD Million)
Figure 32. South America Immunosuppressive Agents Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Immunosuppressive Agents Revenue (2017-2028) & (USD Million)
Figure 34. Global Immunosuppressive Agents Sales Market Share by Type (2017-2028)
Figure 35. Global Immunosuppressive Agents Revenue Market Share by Type (2017-2028)
Figure 36. Global Immunosuppressive Agents Price by Type (2017-2028) & (US$/Ton)
Figure 37. Global Immunosuppressive Agents Sales Market Share by Application (2017-2028)
Figure 38. Global Immunosuppressive Agents Revenue Market Share by Application (2017-2028)
Figure 39. Global Immunosuppressive Agents Price by Application (2017-2028) & (US$/Ton)
Figure 40. North America Immunosuppressive Agents Sales Market Share by Type (2017-2028)
Figure 41. North America Immunosuppressive Agents Sales Market Share by Application (2017-2028)
Figure 42. North America Immunosuppressive Agents Sales Market Share by Country (2017-2028)
Figure 43. North America Immunosuppressive Agents Revenue Market Share by Country (2017-2028)
Figure 44. United States Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Immunosuppressive Agents Sales Market Share by Type (2017-2028)
Figure 48. Europe Immunosuppressive Agents Sales Market Share by Application (2017-2028)
Figure 49. Europe Immunosuppressive Agents Sales Market Share by Country (2017-2028)
Figure 50. Europe Immunosuppressive Agents Revenue Market Share by Country (2017-2028)
Figure 51. Germany Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Immunosuppressive Agents Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Immunosuppressive Agents Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Immunosuppressive Agents Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Immunosuppressive Agents Revenue Market Share by Region (2017-2028)
Figure 60. China Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Immunosuppressive Agents Sales Market Share by Type (2017-2028)
Figure 67. South America Immunosuppressive Agents Sales Market Share by Application (2017-2028)
Figure 68. South America Immunosuppressive Agents Sales Market Share by Country (2017-2028)
Figure 69. South America Immunosuppressive Agents Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Immunosuppressive Agents Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Immunosuppressive Agents Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Immunosuppressive Agents Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Immunosuppressive Agents Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Immunosuppressive Agents Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Immunosuppressive Agents in 2021
Figure 81. Manufacturing Process Analysis of Immunosuppressive Agents
Figure 82. Immunosuppressive Agents Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医薬品用キシリトール市場2022年：市場規模予測（～2028年）
  • 世界の製薬業用ポンプ市場2022年：市場規模予測（～2028年）
  • 世界の医薬品スクリーニング機市場2022年：市場規模予測（～2028年）
  • 世界の経口製剤用医薬品賦形剤市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用魚油市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19415 )"世界の免疫抑制剤市場2022年：市場規模予測（～2028年）" (英文：Global Immunosuppressive Agents Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。